Evidence map›Paper›PMID 22493493›Full record

ArticleThe Journal of biological chemistry2012

Cisplatin-induced ototoxicity is mediated by nitroxidative modification of cochlear proteins characterized by nitration of Lmo4.

Samson Jamesdaniel, Donald Coling, Sneha Hinduja, Dalian Ding, Jun Li, Linda Cassidy, Gail M Seigel, Jun Qu, Richard Salvi

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
1.5field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 46 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Genes · 2023
    Article
  8. Nitrative Stress and Auditory Dysfunction.Pharmaceuticals (Basel, Switzerland) · 2022
    Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. The impact of erdosteine on cisplatin-induced ototoxicity: a proteomics approach.European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2017
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Samson JamesdanielDepartment of Communicative Disorders and Sciences, The State University of New York, Buffalo, New York 14214, USA. sj57@buffalo.edu
Donald Coling
Sneha Hinduja
Dalian Ding
Jun Li
Linda Cassidy
Gail M Seigel
Jun Qu
Richard Salvi
University at Buffalo, State University of New York · US

Funding

TRANS-NETWORK PROJECTSU54CA143876 · NCI · CORNELL UNIVERSITY · PI SHULER, MICHAEL L · 2009 to 2014
$12.6M
Role of protein nitration in cisplatin mediated ototoxicityR03DC010225 · NIDCD · STATE UNIVERSITY OF NEW YORK AT BUFFALO · PI JAMESDANIEL, SAMSON · 2009 to 2011
$467k
Tumor initiating cells in retinoblastomaR21CA127061 · NCI · STATE UNIVERSITY OF NEW YORK AT BUFFALO · PI SEIGEL, GAIL M · 2008 to 2009
$392k
NCI NIH HHS CA127061NCI NIH HHS U54CA143876NIDCD NIH HHS 1 R03 DC010225-01NIDCD NIH HHS R03 DC010225
6 · The paper itself

Abstract

Tyrosine nitration is an important sequel of cellular signaling induced by reactive oxygen species. Cisplatin is an anti-neoplastic agent that damages the inner ear through reactive oxygen species and by the formation of DNA adducts. This study reveals a correlation between cisplatin-mediated hearing loss and nitroxidative modification of cochlear proteins and is the first to report nitration of Lmo4. Cisplatin induced a dose-dependent increase in hearing loss in Wistar rats. A 10-15-dB decrease in distortion product amplitude and massive loss of outer hair cells at the basal turn of the cochlea was observed 3 days post-treatment after a 16 mg/kg dose. Cisplatin induced nitration of cellular proteins within the organ of Corti, spiral ganglion, and stria vascularis, which are known targets of cisplatin ototoxicity. Nitration of a 76-kDa cochlear protein correlated with cisplatin dose. The nitrated protein was identified as Lmo4 (LIM domain only 4) by MALDI-TOF (matrix-assisted laser desorption/ionization time of flight) mass spectrometry and confirmed by reciprocal immunoprecipitation and immunoblotting. Co-localization of nitrotyrosine and Lmo4 was particularly high in outer hair cell nuclei after cisplatin treatment. Cochlear levels of Lmo4 were decreased in rats treated with cisplatin. In vitro studies supported the repression of Lmo4 in nitroxidative conditions and the induction of apoptosis upon repression of Lmo4. Inhibition of cochlear protein nitration prevented cisplatin-induced hearing loss. As Lmo4 is a transcriptional regulator that controls the choice between cell survival and cell death, these results support the hypothesis that nitration of Lmo4 influences cisplatin-induced ototoxicity.

Indexed as

Adaptor Proteins, Signal TransducingAnimalsAntineoplastic AgentsBlotting, WesternCisplatinCochleaLIM Domain ProteinsMaleNitratesRatsRats, WistarSpectrometry, Mass, Matrix-Assisted Laser Desorption-IonizationSubcellular FractionsAdaptor Proteins, Signal TransducingAntineoplastic AgentsCisplatinLIM Domain ProteinsLMO4 protein, ratNitrates

Identifiers

PMID22493493
PMCPMC3365719
OpenAlexW1977158594

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.